Palisade Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-61,433
Closed -$4.93M 138
2016
Q4
$4.93M Sell
61,433
-11,357
-16% -$901K 0.94% 35
2016
Q3
$5.81M Sell
72,790
-4,650
-6% -$375K 1.08% 34
2016
Q2
$6.04M Sell
77,440
-1,440
-2% -$103K 1.14% 33
2016
Q1
$4.34M Buy
78,880
+7,995
+11% +$436K 0.84% 37
2015
Q4
$4.38M Sell
70,885
-2,604
-4% -$164K 0.94% 37
2015
Q3
$4.64M Sell
73,489
-336
-0.5% -$24K 1.04% 33
2015
Q2
$5.39M Sell
73,825
-150
-0.2% -$10.8K 1.07% 31
2015
Q1
$4.84M Buy
73,975
+10,245
+16% +$681K 0.95% 33
2014
Q4
$4.14M Buy
63,730
+75
+0.1% +$4.83K 0.82% 33
2014
Q3
$3.83M Buy
63,655
+630
+1% +$41.2K 0.79% 36
2014
Q2
$4.36M Buy
63,025
+150
+0.2% +$9.72K 0.92% 31
2014
Q1
$4.11M Sell
62,875
-50
-0.1% -$3.25K 0.9% 34
2013
Q4
$3.9M Buy
62,925
+300
+0.5% +$17.4K 0.88% 34
2013
Q3
$3.36M Sell
62,625
-13,800
-18% -$711K 0.86% 36
2013
Q2
$3.49M Buy
+76,425
New +$3.31M 0.88% 37

Other funds holding STJ

Palisade Asset Management's STJ Position: Q1 2017 in Review

Palisade Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 61,433 shares — an estimated $4.93M sold.

Palisade Asset Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $6.04M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Palisade Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Palisade Asset Management sold 61,433 St Jude Medical shares in Q1 2017, an estimated $4.93M.
  • Palisade Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Palisade Asset Management's St Jude Medical position peaked at $6.04M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Palisade Asset Management's 13F filing for Q1 2017, filed 27 Apr 2017.